How Hemoglobinopathies Can Skew A1c Results and What to Do About It

by

Hemoglobin A1c (HbA1c) testing is a common method used to monitor long-term blood glucose control in individuals with diabetes. However, certain blood disorders called hemoglobinopathies can interfere with the accuracy of these tests, leading to misleading results.

What Are Hemoglobinopathies?

Hemoglobinopathies are genetic disorders affecting the structure or production of hemoglobin, the protein in red blood cells that carries oxygen. Common examples include sickle cell disease and thalassemia. These conditions alter the shape, lifespan, or production of red blood cells, impacting various blood tests.

How Do Hemoglobinopathies Affect A1c Results?

The HbA1c test measures the percentage of hemoglobin that has glucose attached over the lifespan of red blood cells, typically around 120 days. In hemoglobinopathies, abnormal hemoglobin variants or altered red blood cell lifespans can skew these measurements. For example:

  • Sickle cell disease can cause falsely low or high HbA1c levels depending on the test method used.
  • Thalassemia may lead to inaccurate readings due to abnormal hemoglobin types.
  • Altered red blood cell lifespan can make HbA1c levels unreliable, as the test depends on normal red cell turnover.

What Are Alternative Monitoring Strategies?

When hemoglobinopathies interfere with HbA1c accuracy, healthcare providers may recommend alternative methods to monitor blood glucose:

  • Fructosamine testing: Measures glycated serum proteins over the past 2-3 weeks, unaffected by hemoglobin variants.
  • Continuous glucose monitoring (CGM): Provides real-time glucose data, giving a comprehensive picture of blood sugar levels.
  • Self-monitoring of blood glucose (SMBG): Regular finger-prick tests remain essential for daily management.

Conclusion

Understanding the impact of hemoglobinopathies on HbA1c results is crucial for accurate diabetes management. Healthcare providers should consider alternative testing methods when necessary to ensure patients receive the most reliable assessment of their blood glucose control.